We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBAY
12901
PUT
DELISTED
Cymabay Therapeutics
CBAY
$35K ﹤0.01%
11,400
-401,300
-97% -$1.26M
ELYS
12902
PUT
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$35K ﹤0.01%
14,900
-8,900
-37% -$23.9K
CLVR
12903
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$35K ﹤0.01%
+470
New +$25.5K
CYAD
12904
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$35K ﹤0.01%
+14,598
New +$44.7K
ASAP
12905
PUT
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$35K ﹤0.01%
4,735
-1,675
-26% -$17.3K
GNACW
12906
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$35K ﹤0.01%
133,333
-2,536
-2% -$1.09K
ZVO
12907
DELISTED
Zovio Inc. Common Stock
ZVO
$35K ﹤0.01%
42,408
+4,629
+12% +$5.21K
THER
12908
DELISTED
THERATECHNOLOGIES INC COM
THER
$35K ﹤0.01%
+14,157
New +$35K
AIFA
12909
All In FutureTech Alliance Inc
AIFA
$12.8M
$34K ﹤0.01%
3,292
-1,960
-37% -$21K
ALGS icon
12910
PUT
Aligos Therapeutics
ALGS
$34.9M
$34K ﹤0.01%
+640
New +$51.3K
EVLV icon
12911
Evolv Technologies
EVLV
$1.1B
$34K ﹤0.01%
12,975
-224,825
-95% -$735K
FBRX icon
12912
CALL
Forte Biosciences
FBRX
$1.57B
$34K ﹤0.01%
924
-2,384
-72% -$90.2K
FTK icon
12913
CALL
Flotek Industries
FTK
$1.28B
$34K ﹤0.01%
+4,533
New +$32.3K
OPTT icon
12914
CALL
Ocean Power Technologies
OPTT
$49.9M
$34K ﹤0.01%
23,800
+13,200
+125% +$16.8K
PASG icon
12915
CALL
Passage Bio
PASG
$14.1M
$34K ﹤0.01%
+555
New +$45.7K
SIEB icon
12916
Siebert Financial
SIEB
$68.4M
$34K ﹤0.01%
15,940
-23,154
-59% -$49.5K
PHLT
12917
PUT
DELISTED
Performant Healthcare Inc
PHLT
$34K ﹤0.01%
10,900
-700
-6% -$1.65K
DXYN
12918
PUT
DELISTED
Dixie Group Inc
DXYN
$34K ﹤0.01%
10,900
-5,600
-34% -$23.3K
SDPI
12919
DELISTED
Superior Drilling Products Inc.
SDPI
$34K ﹤0.01%
32,324
-11,571
-26% -$10.9K
DMK
12920
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$34K ﹤0.01%
863
-684
-44% -$29.4K
FRXB.WS
12921
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$34K ﹤0.01%
78,440
-30,103
-28% -$15K
CORR
12922
CALL
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$34K ﹤0.01%
11,000
-1,800
-14% -$6.24K
PACXW
12923
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$34K ﹤0.01%
164,349
-200
-0.1% -$88
DS
12924
CALL
DELISTED
Drive Shack Inc.
DS
$34K ﹤0.01%
22,100
-46,100
-68% -$62.6K
HCIIW
12925
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$34K ﹤0.01%
89,238
+1,235
+1% +$586

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.